JOURNAL OF REHABILITATION MEDICINE, cilt.51, sa.5, ss.390-394, 2019 (SCI-Expanded)
Objectives: To determine whether switching from onabotulinumtoxin-A to abobotulinumtoxin-A in children with cerebral palsy is safe and whether therapeutic efficacy is maintained.